# OnCo record radiation-roadmap (roadmap). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/roadmaps/radiation-roadmap/>
  a schema:CreativeWork ;
  onco:kind "roadmap" ;
  schema:identifier "radiation-roadmap" ;
  schema:name "Radiotherapy roadmap: X-rays → shaped beams → fewer fractions, particles and FLASH"@en ;
  schema:description "Radiotherapy cures more people than any drug and has reinvented itself every decade: from crude X-ray fields to beams shaped by computer, delivered in days instead of weeks, and now in fractions of a second. Its future is precision, fewer visits, and combination with drugs that make radiation work better."@en ;
  schema:url <https://onco.cc/roadmaps/radiation-roadmap/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(20)30932-6>, <https://www.nejm.org/doi/full/10.1056/NEJMoa1709937>, <https://doi.org/10.1016/S1470-2045(15)00222-3> ;
  onco:related <https://onco.cc/roadmaps/radiopharma-roadmap/>, <https://onco.cc/ideas/idea-acc-single-fraction-palliative-radiotherapy-default/>, <https://onco.cc/ideas/idea-acc-hypofractionation-default-lmic/>, <https://onco.cc/ideas/idea-acc-pooled-procurement-radiotherapy/>, <https://onco.cc/ideas/idea-acc-linac-uptime-contracts/>, <https://onco.cc/ideas/idea-acc-remote-planning-hubs/>, <https://onco.cc/ideas/idea-acc-remote-medical-physics-qa/>, <https://onco.cc/ideas/idea-acc-frugal-hdr-brachytherapy/>, <https://onco.cc/ideas/idea-bio2-radiotherapy-sting-fractionation/>, <https://onco.cc/ideas/idea-cthpv-adapted-deescalation/>, <https://onco.cc/roadmaps/frontier-2035/>, <https://onco.cc/roadmaps/devices-roadmap/> ;
  onco:sections <https://onco.cc/fronts/radiation/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/sbrt/>, <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/technologies/carbon-ion/>, <https://onco.cc/technologies/mr-linac/>, <https://onco.cc/technologies/flash-rt/>, <https://onco.cc/technologies/vhee-radiotherapy/>, <https://onco.cc/technologies/proton-arc-therapy/>, <https://onco.cc/technologies/lattice-radiotherapy/>, <https://onco.cc/technologies/bnct/>, <https://onco.cc/technologies/hyperthermia/>, <https://onco.cc/technologies/radiodynamic-therapy/>, <https://onco.cc/technologies/radioimmunotherapy/>, <https://onco.cc/technologies/targeted-alpha-therapy/>, <https://onco.cc/technologies/radionuclide-parp-combination/>, <https://onco.cc/technologies/auto-contouring-ai/>, <https://onco.cc/technologies/treatment-planning-systems/>, <https://onco.cc/technologies/palliative-radiotherapy/>, <https://onco.cc/technologies/prophylactic-cranial-irradiation/>, <https://onco.cc/technologies/intraoperative-radiotherapy/>, <https://onco.cc/technologies/hyperbaric-oxygen-radiation-injury/>, <https://onco.cc/technologies/acupuncture-xerostomia/> ;
  onco:drugs <https://onco.cc/drugs/durvalumab/>, <https://onco.cc/drugs/temozolomide/>, <https://onco.cc/drugs/radioactive-iodine/>, <https://onco.cc/drugs/amifostine/> ;
  onco:companies <https://onco.cc/companies/varian/>, <https://onco.cc/companies/elekta/>, <https://onco.cc/companies/reflexion/>, <https://onco.cc/companies/theryq/>, <https://onco.cc/companies/iba/>, <https://onco.cc/companies/mevion/>, <https://onco.cc/companies/raysearch/>, <https://onco.cc/companies/leo-cancer-care/>, <https://onco.cc/companies/p-cure/>, <https://onco.cc/companies/tae-life-sciences/>, <https://onco.cc/companies/neutron-therapeutics/>, <https://onco.cc/companies/limbus-ai/>, <https://onco.cc/companies/therapanacea/>, <https://onco.cc/companies/nrg-oncology/> ;
  onco:institutions <https://onco.cc/institutions/the-christie/>, <https://onco.cc/institutions/institut-curie/>, <https://onco.cc/institutions/mayo-clinic-florida/>, <https://onco.cc/institutions/mgh/> ;
  onco:terms <https://onco.cc/terms/hypofractionation/> ;
  onco:trials <https://onco.cc/trials/pacific/>, <https://onco.cc/trials/laura/>, <https://onco.cc/trials/keynote-a18/>, <https://onco.cc/trials/cross/>, <https://onco.cc/trials/interlace/>, <https://onco.cc/trials/portec-3/>, <https://onco.cc/trials/convert/>, <https://onco.cc/trials/javelin-hn-100/>, <https://onco.cc/trials/trilynx/>, <https://onco.cc/trials/nrg-hn002-hn005/>, <https://onco.cc/trials/estimabl2/>, <https://onco.cc/trials/acns0331/>, <https://onco.cc/trials/eortc-26981/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-surgery-radiation-innovation/>, <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-workforce/>, <https://onco.cc/bottlenecks/b-trial-design/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-atun-lancet-oncol/>, <https://onco.cc/key-papers/paper-murray-brunt-lancet/> .